Form D · Pharmaceuticals
CasaHealth Tech Inc.
Surrey, A1 · CIK 0001760700
Offering snapshot reported Feb 21, 2019 · SEC filing
- Reported sold
- $245K Offering amount: $245K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 15, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 21, 2019 | Initial | $244,987 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-333274
Cdn$1.3266=US$1.00
Class A Preferred Shares
Source: Form D, filed Feb 21, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rajdev Gulia | Director, Executive |
| Abhinav Gupta | Director, Executive |
| Harjeet Samra | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
#233, 18525 53rd Avenue
Surrey, A1, V3S 7A4
Surrey, A1, V3S 7A4